Piperidine → HCID 67064373, compound

HRID 1409173Notes

Reaction equation

HRID 1409173 reaction equation
Cl[C:2]1[N:7]2[N:8]=[C:9]([CH3:11])[CH:10]=[C:6]2[N:5]=[C:4]([NH:12][C:13](=[O:24])[C:14]2[CH:19]=[CH:18][C:17]([C:20]([OH:23])([CH3:22])[CH3:21])=[CH:16][CH:15]=2)[CH:3]=1.[NH:25]1[CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]1>CN(C=O)C.CS(C)=O.CO>[OH:23][C:20]([C:17]1[CH:18]=[CH:19][C:14]([C:13]([NH:12][C:4]2[CH:3]=[C:2]([N:25]3[CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]3)[N:7]3[N:8]=[C:9]([CH3:11])[CH:10]=[C:6]3[N:5]=2)=[O:24])=[CH:15][CH:16]=1)([CH3:22])[CH3:21]

Participants

6

Reactant 2

HCID 8082PiperidineHCID 86652267N-(7-chloro-2-methylpyrazolo[1,5-a]pyrimidin-5-yl)-4-(2-hydroxypropan-2-yl)benzamide

Product 1

HCID 67064373HCID 67064373, compoundYield 52.5%

Reagents, catalysts & solvents 3

HCID 679Dimethyl SulfoxideCatalystHCID 887MethanolSolventHCID 6228DimethylformamideSolvent

Procedure

A solution of N-(7-chloro-2-methylpyrazolo[1,5-a]pyrimidin-5-yl)-4-(2-hydroxypropan-2-yl)benzamide (2F, 52 mg, 0.151 mmol) and piperidine (52 mg, 0.603 mmol) in DMF (0.5 mL) was stirred at 100° C. for 3 h. After cooling to room temperature, the mixture was diluted with a few drops of DMSO and methanol, and was then purified by preparatory HPLC (35-45% MeCN/H2O+0.01% TFA). Lyophilization of the combined fractions gave the titled compound as a white solid (31.2 mg, 52%). 1H NMR (400 MHz, DMSO-d6) δ ppm 1.45 (s, 6H), 1.70 (br. s., 6H), 2.37 (s, 3H), 3.73 (br. s., 4H), 6.16 (s, 1H), 7.28 (s, 1H), 7.60 (d, J=8.59 Hz, 2H), 7.99 (d, J=8.59 Hz, 2H), 10.84 (s, 1H); ESI-MS: m/z 394.3 (M+H)+.

Workup

  1. customwas then purified by preparatory HPLC (35-45% MeCN/H2O+0.01% TFA)

Sources & evidence

ORD record
ord-17d42f9f4bc542d699924f4a8f0b107a
Source dataset
uspto-grants-2014_12
Patent number
US08921358B2

Reaction notes

Loading…